Medicare Enrolled
Dr. Maggie Tavdy, M.D.
Endocrinology · Yonkers, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tavdy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tavdy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tavdy
Dr. Maggie Tavdy is an endocrinology specialist in Yonkers, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tavdy performed 3,505 Medicare services across 2,234 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tavdy received a total of $28,053 from 59 pharmaceutical and/or device companies across 544 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tavdy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in NY
$28,053 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,505
Medicare services
Top 19% in NY for endocrinology
2,234
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~184 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,499 | $108 | $175 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
426 | $30 | $50 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
214 | $30 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
205 | $8 | $17 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
168 | $102 | $200 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
137 | $44 | $60 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
113 | $77 | $116 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
93 | $13 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
83 | $1 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $134 | $226 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
72 | $36 | $40 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
71 | $4 | $20 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
52 | $136 | $250 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
51 | $76 | $80 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
48 | $88 | $121 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
45 | $66 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $77 | $125 |
| Hemoglobin a1c level, by device for home use | 29 | $10 | $50 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 22 | $20 | $40 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $50 | $80 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
19 | $149 | $350 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $11 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,053
Total received (2018-2024)
Avg $4,008/year across 7 years
Top 13% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
544
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,467 (51.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,586 (48.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,018
2023
$2,037
2022
$2,237
2021
$1,925
2020
$7,306
2019
$8,422
2018
$4,108
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$236
Amgen Inc.
$212
Amneal Pharmaceuticals LLC
$202
Novo Nordisk Inc
$168
Corcept Therapeutics
$153
Medtronic, Inc.
$138
Axsome Therapeutics, Inc.
$125
Phathom Pharmaceuticals, Inc.
$123
ACADIA Pharmaceuticals Inc
$119
CeQur Corporation
$110
ABBVIE INC.
$103
ARGENX US, INC.
$101
AstraZeneca Pharmaceuticals LP
$59
Alexion Pharmaceuticals, Inc.
$56
Mannkind Corporation
$30
Ascendis Pharma Inc
$26
RECORDATI_RARE_DISEASES_INC.
$22
SANOFI-AVENTIS U.S. LLC
$20
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$15,064
Amgen Inc.
$1,680
Novo Nordisk Inc
$1,045
Lilly USA, LLC
$915
Amarin Pharma Inc.
$806
Merck Sharp & Dohme Corporation
$582
AbbVie Inc.
$575
Medtronic, Inc.
$510
Janssen Pharmaceuticals, Inc
$407
Amneal Pharmaceuticals LLC
$400
Abbott Laboratories
$343
CeQur Corporation
$336
MannKind Corporation
$317
Radius Health, Inc.
$281
Intuity Medical Inc
$279
Bayer HealthCare Pharmaceuticals Inc.
$266
AbbVie, Inc.
$260
ABBVIE INC.
$196
SANOFI-AVENTIS U.S. LLC
$194
Zealand Pharma US, Inc.
$182
Mannkind Corporation
$165
Corcept Therapeutics
$165
Insulet Corporation
$158
Kowa Pharmaceuticals America, Inc.
$138
Amryt Pharma Holdings Ltd
$136
Antares Pharma, Inc.
$135
Astellas Pharma US Inc
$133
Valeritas, Inc.
$131
Biohaven Pharmaceuticals, Inc.
$125
Axsome Therapeutics, Inc.
$125
Shire North American Group Inc
$125
Phathom Pharmaceuticals, Inc.
$123
ACADIA Pharmaceuticals Inc
$119
Philips Electronics North America Corporation
$118
Boston Scientific Corporation
$116
Xeris Pharmaceuticals, Inc.
$115
Horizon Therapeutics plc
$114
Clarus Therapeutics Inc.
$112
IBSA Pharma Inc.
$112
ARGENX US, INC.
$101
Medtronic MiniMed, Inc.
$91
Alfasigma USA, Inc.
$81
Eisai Inc.
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$76
RECORDATI_RARE_DISEASES_INC.
$65
Currax Pharmaceuticals LLC
$63
Alexion Pharmaceuticals, Inc.
$56
PFIZER INC.
$47
Bayer Healthcare Pharmaceuticals Inc.
$44
EUSA Pharma (US) LLC
$43
Daiichi Sankyo Inc.
$42
Esperion Therapeutics, Inc.
$29
Exeltis, USA Inc.
$28
Ascendis Pharma Inc
$26
LIFESCAN, INC.
$25
EISAI INC.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Tandem Diabetes Care, Inc.
$12
Avanir Pharmaceuticals, Inc.
$11
Top 3 companies account for 63.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AFREZZA · Aimovig · Auvelity · BAQSIMI · BASAGLAR · BELSOMRA · BOTOX · Belviq · CHANTIX · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JENTADUETO · Kerendia · Korlym · LINZESS · LOKELMA · LYRICA · LYUMJEV · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · MYRBETRIQ · Minimed 670G System · Minimed 770G System · NEXLETOL · NOCDURNA · NUEDEXTA · NUPLAZID · NURTEC ODT · Omnipod · Otezla · Otrexup · Ozempic · PURIFIED CORTROPHIN GEL · Pogo Automatic Blood Glucose Monitoring System · Prolia · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Trilogy 100 · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VOQUEZNA · VPRIV · VRAYLAR · VYVGART HYTRULO · Vascepa · Veozah · Victoza · WATCHMAN · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEGALOGUE · ZEPBOUND · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Endocrinologists within 10 mi
660
Per 100K population
66.2
County median income
$118,411
Nearest hospital
ST JOSEPH'S MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tavdy is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY), with speaking/promotional industry engagement in the top 13% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tavdy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tavdy performed 1,499 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tavdy receive payments from pharmaceutical companies?
Yes. Dr. Tavdy received a total of $28,053 from 59 companies across 544 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tavdy's costs compare to other endocrinologists in Yonkers?
Dr. Tavdy's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tavdy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Yonkers
Browse endocrinologists in Yonkers ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology